title: The optic neuritis treatment trial: implications for clinicians.
authors.affiliation: Neuro-Ophthalmology Unit, California Pacific Medical Center, San Francisco, USA.
authors.forename: B
authors.initials: B
authors.lastname: Katz
authors.forename: J D
authors.initials: JD
authors.lastname: Trobe
authors.forename: R W
authors.initials: RW
authors.lastname: Beck
mesh_terms: D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000517:prevention & control; D009902:Optic Neuritis / Q000188:drug therapy* / Q000503:physiopathology; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic